Once a week.
Subscribe to our weekly newsletter.
Why do some species evolve to miniaturize?
The island rule hypothesizes that species shrink or supersize to fill insular niches not available to them on the mainland.
- Brookesia nana, the nano-chameleon, may be the smallest vertebrate ever discovered.
- The "island rule" states that when new species migrate to islands, they may shrink or grow as they evolve to fill new ecological niches.
- It remains unclear whether the island rule can explain the nano-chameleon or nature's other extreme miniaturizations.
The newly discovered nano-chameleon (Brookesia nana) is the latest contender for the title of the world's smallest reptile and amniote vertebrate. Found in a mountainous region in northern Madagascar, the males of this diminutive species sport a body size of 13.5 mm, meaning one could comfortably stand on the end of your finger.
Its wee challenger is the Jaragua dwarf gecko (Sphaerodactylus ariasae). These pocket-change-sized geckos—the genus is often pictured snogging the minted portraits of past presidents—come in at 16 mm from nose to tail. They were discovered in 2001 on Isla Beata, a small, forested Caribbean island just south of the Dominican Republic.
The title of the world's smallest, however, is difficult to award thanks to sexual size dimorphism. As Dr. Mark Scherz, herpetologist and evolutionary biologist, pointed out on his blog, nano-chameleon females are significantly larger than their male counterparts or Jaragua dwarf gecko females. "As a result, whether or not the new species is considered the smallest amniote in the world depends on whether we define that based on the male or female body size, or the midpoint of the two. It turns out this is quite a common problem in other species with size dimorphism as well, such as frogs," Scherz writes.
Beyond their shrimpy stature, these and other miniaturized species have another thing in common: They live on islands. That fact may explain why evolution has pushed them to shrink in a world full of giant competition.
Bigger isn't always better
The New Zealand little spotted kiwi evolved to be small to fill an ecological niche. Before the arrival of humans, its island ecosystem contained no land mammals to prey on these flightless birds.
Credit: Wikimedia Commons
Because of their geographic isolation, islands can have powerful effects on the evolution of their residential species. The massive Komodo dragon prowls its namesake island. The Barbados threadsnake is thin enough to slither through a straw. And the fossil record recounts a history of unusually sized and bedecked creatures who established homes far from the mainland, such as the Hoplitomeryx of the Mikrotia fauna.
One hypothesis for evolution's insular experimentation is "the island rule." The rule states that after establishing themselves on an island, smaller species will tend to evolve into oversized versions of their mainland ancestors. Meanwhile, larger species will tend to evolve into smaller variations. These processes are known as insular gigantism and insular dwarfism, respectively. They do this to fill the ecological niches available to them, which often differ from those they filled on the mainland.
The rule was first formulated by evolutionary biologist Leigh Van Valen and based on a 1964 study by mammologist J. Bristol Foster—which is why it is also known as Foster's rule. Since then, many observational studies have corroborated the island rule, and there is even evidence to suggest that new species introduced to islands will, for a time, evolve more rapidly to fill available niches.
A flock of migrant birds, for example, may find an island's lack of mammalian and reptilian predators opens the ground-living niche once forbidden to them. Such birds would then be free to grow larger, forage below the canopies, and lose the ability of flight.
This appears to be the origin story for New Zealand's flightless birds including the giant moa, which, at six-feet tall, is the tallest bird on record. This megafauna enjoyed all the benefits of being large and in charge: fewer predators, wider ranges, access to more and varied foods, and the ability to better survive trying times. The species enjoyed island life until roughly 600 years ago, when humans arrived on the scene and hunted them to extinction.
Conversely, large species may find island living restrictive as there's less room or food when compared to their mainland nurseries. Because of this, evolution may select for smaller body sizes as such bodies require less energy, and therefore fewer resources, to survive and reproduce.
This is the theory behind the miniaturization of the Channel Islands pygmy mammoths. As the story goes, in the search for food, a herd of Columbian mammoths embarked on a journey to the super island Santaroasae. Over time, the island was cut off from the mainland. Food became scarce, and smaller mammoths had an easier time surviving and reproducing, thus passing on their Shrinky-Dink genes. Thanks to a lack of oversized predators, such evolution proved fruitful, and in less than 20,000 years, the giant Columbian mammoths evolved into a new species—the (relatively) pint-sized, 6.5-foot-tall pygmy mammoths.
To be clear, the island rule doesn't state that any species that washes ashore must go either Lilliputian or Brobdingnag. It only states that if an ecological niche becomes available and improves survival and reproductive success, then such a change is likely.
Thanks to that island living?
Such constrained growth may be the cause of the Jaragua dwarf gecko's bantam evolution. The gecko eats tiny insects and may be filling a niche that's unavailable on the North American continent with its many, many insectivores. In fact, the island rule may explain why islands are so rich with endemic species—particularly the Caribbean, which is considered a biodiversity hotspot.
Of course, scientific rules are only provisional, and scientists are prepared to revise or completely disregard a hypothesis should new evidence appear. In a field as new as biogeography, the question of whether the island rule is truly a "rule" remains an open and hotly debated question.
One systematic review found empirical support for the island rule to be low, while another analysis argued the rule is simply a recognition of "a few clade-specific patterns." The latter's authors conclude that "[i]nstead of a rule, size evolution on islands is likely to be governed by the biotic and abiotic characteristics of different islands, the biology of the species in question and contingency."
That brings us back to the newly discovered nano-chameleon. While it seems to follow the island rule—Madagascar being an island known for its rich biodiversity—there is a wrinkle. The species' closest relative lives right next door. Brookesia karchei is near twice the size of the nano-chameleon but ranges in the same mountains on mainland Madagascar.
If the nano-chameleon evolved to fill an ecological niche, why didn't those same environmental pressures miniaturize the karchei chameleon? If not the island rule, what did lead to the nano-chameleon's smaller size? As is often the case in science, further evidence may one day answer these questions.
- 83 - A Voyage to the Country of the Houyhnhnms - Big Think ›
- The World's Littlest Lizards Fit on the End of a Q-Tip - Big Think ›
Scientists are using bioelectronic medicine to treat inflammatory diseases, an approach that capitalizes on the ancient "hardwiring" of the nervous system.
- Bioelectronic medicine is an emerging field that focuses on manipulating the nervous system to treat diseases.
- Clinical studies show that using electronic devices to stimulate the vagus nerve is effective at treating inflammatory diseases like rheumatoid arthritis.
- Although it's not yet approved by the US Food and Drug Administration, vagus nerve stimulation may also prove effective at treating other diseases like cancer, diabetes and depression.
The nervous system’s ancient reflexes<p>You accidentally place your hand on a hot stove. Almost instantaneously, your hand withdraws.</p><p>What triggered your hand to move? The answer is <em>not</em> that you consciously decided the stove was hot and you should move your hand. Rather, it was a reflex: Skin receptors on your hand sent nerve impulses to the spinal cord, which ultimately sent back motor neurons that caused your hand to move away. This all occurred before your "conscious brain" realized what happened.</p><p>Similarly, the nervous system has reflexes that protect individual cells in the body.</p><p>"The nervous system evolved because we need to respond to stimuli in the environment," said Dr. Tracey. "Neural signals don't come from the brain down first. Instead, when something happens in the environment, our peripheral nervous system senses it and sends a signal to the central nervous system, which comprises the brain and spinal cord. And then the nervous system responds to correct the problem."</p><p>So, what if scientists could "hack" into the nervous system, manipulating the electrical activity in the nervous system to control molecular processes and produce desirable outcomes? That's the chief goal of bioelectronic medicine.</p><p>"There are billions of neurons in the body that interact with almost every cell in the body, and at each of those nerve endings, molecular signals control molecular mechanisms that can be defined and mapped, and potentially put under control," Dr. Tracey said in a <a href="https://www.youtube.com/watch?v=AJH9KsMKi5M" target="_blank">TED Talk</a>.</p><p>"Many of these mechanisms are also involved in important diseases, like cancer, Alzheimer's, diabetes, hypertension and shock. It's very plausible that finding neural signals to control those mechanisms will hold promises for devices replacing some of today's medication for those diseases."</p><p>How can scientists hack the nervous system? For years, researchers in the field of bioelectronic medicine have zeroed in on the longest cranial nerve in the body: the vagus nerve.</p>
The vagus nerve<img type="lazy-image" data-runner-src="https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTYyOTM5OC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTY0NTIwNzk0NX0.UCy-3UNpomb3DQZMhyOw_SQG4ThwACXW_rMnc9mLAe8/img.jpg?width=1245&coordinates=0%2C0%2C0%2C0&height=700" id="09add" class="rm-shortcode" data-rm-shortcode-id="f38dbfbbfe470ad85a3b023dd5083557" data-rm-shortcode-name="rebelmouse-image" data-width="1245" data-height="700" />
Electrical signals, seen here in a synapse, travel along the vagus nerve to trigger an inflammatory response.
Credit: Adobe Stock via solvod<p>The vagus nerve ("vagus" meaning "wandering" in Latin) comprises two nerve branches that stretch from the brainstem down to the chest and abdomen, where nerve fibers connect to organs. Electrical signals constantly travel up and down the vagus nerve, facilitating communication between the brain and other parts of the body.</p><p>One aspect of this back-and-forth communication is inflammation. When the immune system detects injury or attack, it automatically triggers an inflammatory response, which helps heal injuries and fend off invaders. But when not deployed properly, inflammation can become excessive, exacerbating the original problem and potentially contributing to diseases.</p><p>In 2002, Dr. Tracey and his colleagues discovered that the nervous system plays a key role in monitoring and modifying inflammation. This occurs through a process called the <a href="https://www.nature.com/articles/nature01321" target="_blank" rel="noopener noreferrer">inflammatory reflex</a>. In simple terms, it works like this: When the nervous system detects inflammatory stimuli, it reflexively (and subconsciously) deploys electrical signals through the vagus nerve that trigger anti-inflammatory molecular processes.</p><p>In rodent experiments, Dr. Tracey and his colleagues observed that electrical signals traveling through the vagus nerve control TNF, a protein that, in excess, causes inflammation. These electrical signals travel through the vagus nerve to the spleen. There, electrical signals are converted to chemical signals, triggering a molecular process that ultimately makes TNF, which exacerbates conditions like rheumatoid arthritis.</p><p>The incredible chain reaction of the inflammatory reflex was observed by Dr. Tracey and his colleagues in greater detail through rodent experiments. When inflammatory stimuli are detected, the nervous system sends electrical signals that travel through the vagus nerve to the spleen. There, the electrical signals are converted to chemical signals, which trigger the spleen to create a white blood cell called a T cell, which then creates a neurotransmitter called acetylcholine. The acetylcholine interacts with macrophages, which are a specific type of white blood cell that creates TNF, a protein that, in excess, causes inflammation. At that point, the acetylcholine triggers the macrophages to stop overproducing TNF – or inflammation.</p><p>Experiments showed that when a specific part of the body is inflamed, specific fibers within the vagus nerve start firing. Dr. Tracey and his colleagues were able to map these relationships. More importantly, they were able to stimulate specific parts of the vagus nerve to "shut off" inflammation.</p><p>What's more, clinical trials show that vagus nerve stimulation not only "shuts off" inflammation, but also triggers the production of cells that promote healing.</p><p>"In animal experiments, we understand how this works," Dr. Tracey said. "And now we have clinical trials showing that the human response is what's predicted by the lab experiments. Many scientific thresholds have been crossed in the clinic and the lab. We're literally at the point of regulatory steps and stages, and then marketing and distribution before this idea takes off."<br></p>
The future of bioelectronic medicine<img type="lazy-image" data-runner-src="https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTYxMDYxMy9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTYzNjQwOTExNH0.uBY1TnEs_kv9Dal7zmA_i9L7T0wnIuf9gGtdRXcNNxo/img.jpg?width=980" id="8b5b2" class="rm-shortcode" data-rm-shortcode-id="c005e615e5f23c2817483862354d2cc4" data-rm-shortcode-name="rebelmouse-image" data-width="2000" data-height="1125" />
Vagus nerve stimulation can already treat Crohn's disease and other inflammatory diseases. In the future, it may also be used to treat cancer, diabetes, and depression.
Credit: Adobe Stock via Maridav<p>Vagus nerve stimulation is currently awaiting approval by the US Food and Drug Administration, but so far, it's proven safe and effective in clinical trials on humans. Dr. Tracey said vagus nerve stimulation could become a common treatment for a wide range of diseases, including cancer, Alzheimer's, diabetes, hypertension, shock, depression and diabetes.</p><p>"To the extent that inflammation is the problem in the disease, then stopping inflammation or suppressing the inflammation with vagus nerve stimulation or bioelectronic approaches will be beneficial and therapeutic," he said.</p><p>Receiving vagus nerve stimulation would require having an electronic device, about the size of lima bean, surgically implanted in your neck during a 30-minute procedure. A couple of weeks later, you'd visit, say, your rheumatologist, who would activate the device and determine the right dosage. The stimulation would take a few minutes each day, and it'd likely be unnoticeable.</p><p>But the most revolutionary aspect of bioelectronic medicine, according to Dr. Tracey, is that approaches like vagus nerve stimulation wouldn't come with harmful and potentially deadly side effects, as many pharmaceutical drugs currently do.</p><p>"A device on a nerve is not going to have systemic side effects on the body like taking a steroid does," Dr. Tracey said. "It's a powerful concept that, frankly, scientists are quite accepting of—it's actually quite amazing. But the idea of adopting this into practice is going to take another 10 or 20 years, because it's hard for physicians, who've spent their lives writing prescriptions for pills or injections, that a computer chip can replace the drug."</p><p>But patients could also play a role in advancing bioelectronic medicine.</p><p>"There's a huge demand in this patient cohort for something better than they're taking now," Dr. Tracey said. "Patients don't want to take a drug with a black-box warning, costs $100,000 a year and works half the time."</p><p>Michael Dowling, president and CEO of Northwell Health, elaborated:</p><p>"Why would patients pursue a drug regimen when they could opt for a few electronic pulses? Is it possible that treatments like this, pulses through electronic devices, could replace some drugs in the coming years as preferred treatments? Tracey believes it is, and that is perhaps why the pharmaceutical industry closely follows his work."</p><p>Over the long term, bioelectronic approaches are unlikely to completely replace pharmaceutical drugs, but they could replace many, or at least be used as supplemental treatments.</p><p>Dr. Tracey is optimistic about the future of the field.</p><p>"It's going to spawn a huge new industry that will rival the pharmaceutical industry in the next 50 years," he said. "This is no longer just a startup industry. [...] It's going to be very interesting to see the explosive growth that's going to occur."</p>
Researchers figure out the average temperatures of the last ice age on Earth.
- A new study analyzes fossil data to find the average temperatures during the last Ice Age.
- This period of time, about 20,000 years ago, had the average temperature of about 46 degrees Fahrenheit (7.8 C).
- The study has implications for understanding climate change.
Surface air temperatures during the last ice age.
Credit: Jessica Tierney, University of Arizona
"The Expanse" is the best vision I've ever seen of a space-faring future that may be just a few generations away.
- Want three reasons why that headline is justified? Characters and acting, universe building, and science.
- For those who don't know, "The Expanse" is a series that's run on SyFy and Amazon Prime set about 200 years in the future in a mostly settled solar system with three waring factions: Earth, Mars, and Belters.
- No other show I know of manages to use real science so adeptly in the service of its story and its grand universe building.
Credit: "The Expanse" / Syfy<p>Now, I get it if you don't agree with me. I love "Star Trek" and I thought "Battlestar Galactica" (the new one) was amazing and I do adore "The Mandalorian". They are all fun and important and worth watching and thinking about. And maybe you love them more than anything else. But when you sum up the acting, the universe building, and the use of real science where it matters, I think nothing can beat "The Expanse". And with a <a href="https://www.rottentomatoes.com/tv/the_expanse" target="_blank">Rotten Tomato</a> average rating of 93%, I'm clearly not the only one who feels this way.</p><p>Best.</p><p>Show.</p><p>Ever. </p>
Contrary to what some might think, the brain is a very plastic organ.
As with many other physicians, recommending physical activity to patients was just a doctor chore for me – until a few years ago. That was because I myself was not very active.